Wall Street analysts expect Amdocs Limited (NASDAQ:DOX) to announce $1.01 billion in sales for the current quarter, Zacks reports. Four analysts have made estimates for Amdocs’ earnings, with the highest sales estimate coming in at $1.01 billion and the lowest estimate coming in at $1.00 billion. Amdocs posted sales of $977.71 million during the same quarter last year, which suggests a positive year-over-year growth rate of 3.3%. The company is scheduled to issue its next earnings results on Tuesday, January 29th.
On average, analysts expect that Amdocs will report full year sales of $4.09 billion for the current fiscal year, with estimates ranging from $4.07 billion to $4.09 billion. For the next financial year, analysts anticipate that the business will report sales of $4.22 billion, with estimates ranging from $4.17 billion to $4.26 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research analysts that follow Amdocs.
Amdocs (NASDAQ:DOX) last announced its quarterly earnings data on Thursday, November 8th. The technology company reported $0.90 earnings per share for the quarter, missing analysts’ consensus estimates of $0.92 by ($0.02). The company had revenue of $1 billion for the quarter, compared to analysts’ expectations of $1 billion. Amdocs had a net margin of 8.92% and a return on equity of 15.06%. Amdocs’s quarterly revenue was up 2.3% compared to the same quarter last year. During the same period last year, the firm earned $0.94 earnings per share.
Large investors have recently bought and sold shares of the business. Nelson Van Denburg & Campbell Wealth Management Group LLC raised its position in shares of Amdocs by 12.5% in the second quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 9,662 shares of the technology company’s stock worth $640,000 after acquiring an additional 1,073 shares during the period. Massachusetts Financial Services Co. MA increased its holdings in shares of Amdocs by 6.2% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 6,446,127 shares of the technology company’s stock worth $425,316,000 after acquiring an additional 375,255 shares during the period. Paloma Partners Management Co increased its holdings in shares of Amdocs by 85.0% in the 2nd quarter. Paloma Partners Management Co now owns 9,817 shares of the technology company’s stock worth $650,000 after acquiring an additional 4,511 shares during the period. Stevens Capital Management LP increased its holdings in shares of Amdocs by 663.4% in the 2nd quarter. Stevens Capital Management LP now owns 41,124 shares of the technology company’s stock worth $2,722,000 after acquiring an additional 35,737 shares during the period. Finally, Carillon Tower Advisers Inc. increased its holdings in shares of Amdocs by 49.2% in the 2nd quarter. Carillon Tower Advisers Inc. now owns 55,700 shares of the technology company’s stock worth $3,686,000 after acquiring an additional 18,357 shares during the period. 90.89% of the stock is currently owned by institutional investors.
Shares of DOX traded up $0.40 during trading hours on Thursday, reaching $64.91. 473,960 shares of the company traded hands, compared to its average volume of 950,772. The firm has a market capitalization of $9.25 billion, a PE ratio of 17.36, a price-to-earnings-growth ratio of 1.94 and a beta of 0.52. Amdocs has a 12-month low of $60.50 and a 12-month high of $71.72.
The firm also recently declared a quarterly dividend, which will be paid on Friday, January 18th. Shareholders of record on Monday, December 31st will be issued a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 1.54%. The ex-dividend date is Friday, December 28th. Amdocs’s payout ratio is 26.74%.
Amdocs Limited, through its subsidiaries, provides software and services solutions to the communications, entertainment, pay TV, and media industry service providers worldwide. The company offers customer experience and monetization solutions that allow its customers to contextual and personalize interactions.
Featured Story: How to calculate compound interest
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.